179 related articles for article (PubMed ID: 35102236)
21. Activin E Controls Energy Homeostasis in Both Brown and White Adipose Tissues as a Hepatokine.
Hashimoto O; Funaba M; Sekiyama K; Doi S; Shindo D; Satoh R; Itoi H; Oiwa H; Morita M; Suzuki C; Sugiyama M; Yamakawa N; Takada H; Matsumura S; Inoue K; Oyadomari S; Sugino H; Kurisaki A
Cell Rep; 2018 Oct; 25(5):1193-1203. PubMed ID: 30380411
[TBL] [Abstract][Full Text] [Related]
22. Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer.
Togashi Y; Kogita A; Sakamoto H; Hayashi H; Terashima M; de Velasco MA; Sakai K; Fujita Y; Tomida S; Kitano M; Okuno K; Kudo M; Nishio K
Cancer Lett; 2015 Jan; 356(2 Pt B):819-27. PubMed ID: 25449777
[TBL] [Abstract][Full Text] [Related]
23. SMAD2 and SMAD3 differentially regulate adiposity and the growth of subcutaneous white adipose tissue.
Kumari R; Irudayam MJ; Al Abdallah Q; Jones TL; Mims TS; Puchowicz MA; Pierre JF; Brown CW
FASEB J; 2021 Dec; 35(12):e22018. PubMed ID: 34731499
[TBL] [Abstract][Full Text] [Related]
24. CXCR4 in Tumor Epithelial Cells Mediates Desmoplastic Reaction in Pancreatic Ductal Adenocarcinoma.
Morita T; Kodama Y; Shiokawa M; Kuriyama K; Marui S; Kuwada T; Sogabe Y; Matsumori T; Kakiuchi N; Tomono T; Mima A; Ueda T; Tsuda M; Yamauchi Y; Nishikawa Y; Sakuma Y; Ota Y; Maruno T; Uza N; Nagasawa T; Chiba T; Seno H
Cancer Res; 2020 Oct; 80(19):4058-4070. PubMed ID: 32606001
[TBL] [Abstract][Full Text] [Related]
25. Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice.
Jandaghi P; Najafabadi HS; Bauer AS; Papadakis AI; Fassan M; Hall A; Monast A; von Knebel Doeberitz M; Neoptolemos JP; Costello E; Greenhalf W; Scarpa A; Sipos B; Auld D; Lathrop M; Park M; Büchler MW; Strobel O; Hackert T; Giese NA; Zogopoulos G; Sangwan V; Huang S; Riazalhosseini Y; Hoheisel JD
Gastroenterology; 2016 Dec; 151(6):1218-1231. PubMed ID: 27578530
[TBL] [Abstract][Full Text] [Related]
26. Serum insulin-like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma-associated malnutrition and muscle wasting.
Dong J; Yu J; Li Z; Gao S; Wang H; Yang S; Wu L; Lan C; Zhao T; Gao C; Liu Z; Wang X; Hao J
J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):704-716. PubMed ID: 33763996
[TBL] [Abstract][Full Text] [Related]
27. PYK2 Is Involved in Premalignant Acinar Cell Reprogramming and Pancreatic Ductal Adenocarcinoma Maintenance by Phosphorylating β-Catenin
Gao C; Chen G; Zhang DH; Zhang J; Kuan SF; Hu W; Esni F; Gao X; Guan JL; Chu E; Hu J
Cell Mol Gastroenterol Hepatol; 2019; 8(4):561-578. PubMed ID: 31330317
[TBL] [Abstract][Full Text] [Related]
28. Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment.
Sainz B; Alcala S; Garcia E; Sanchez-Ripoll Y; Azevedo MM; Cioffi M; Tatari M; Miranda-Lorenzo I; Hidalgo M; Gomez-Lopez G; Cañamero M; Erkan M; Kleeff J; García-Silva S; Sancho P; Hermann PC; Heeschen C
Gut; 2015 Dec; 64(12):1921-35. PubMed ID: 25841238
[TBL] [Abstract][Full Text] [Related]
29. Establishment and characterization of a novel murine model of pancreatic cancer cachexia.
Michaelis KA; Zhu X; Burfeind KG; Krasnow SM; Levasseur PR; Morgan TK; Marks DL
J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):824-838. PubMed ID: 28730707
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells.
Li L; Li Z; Kong X; Xie D; Jia Z; Jiang W; Cui J; Du Y; Wei D; Huang S; Xie K
Gastroenterology; 2014 Aug; 147(2):485-97.e18. PubMed ID: 24859161
[TBL] [Abstract][Full Text] [Related]
31. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A
Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299
[TBL] [Abstract][Full Text] [Related]
32. Adipose Triglyceride Lipase (ATGL) Expression Is Associated with Adiposity and Tumor Stromal Proliferation in Patients with Pancreatic Ductal Adenocarcinoma.
Grace SA; Meeks MW; Chen Y; Cornwell M; Ding X; Hou P; Rutgers JK; Crawford SE; Lai JP
Anticancer Res; 2017 Feb; 37(2):699-703. PubMed ID: 28179319
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
[TBL] [Abstract][Full Text] [Related]
34.
Maddalena M; Mallel G; Nataraj NB; Shreberk-Shaked M; Hassin O; Mukherjee S; Arandkar S; Rotkopf R; Kapsack A; Lambiase G; Pellegrino B; Ben-Isaac E; Golani O; Addadi Y; Hajaj E; Eilam R; Straussman R; Yarden Y; Lotem M; Oren M
Proc Natl Acad Sci U S A; 2021 Jun; 118(23):. PubMed ID: 34088837
[TBL] [Abstract][Full Text] [Related]
35. Optimization of a mouse model of pancreatic cancer to simulate the human phenotypes of metastasis and cachexia.
Spadafora V; Pryce BR; Oles A; Talbert EE; Romeo M; Vaena S; Berto S; Ostrowski MC; Wang DJ; Guttridge DC
BMC Cancer; 2024 Apr; 24(1):414. PubMed ID: 38570770
[TBL] [Abstract][Full Text] [Related]
36. Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice.
Ishiguro S; Yoshimura K; Tsunedomi R; Oka M; Takao S; Inui M; Kawabata A; Wall T; Magafa V; Cordopatis P; Tzakos AG; Tamura M
Cancer Biol Ther; 2015; 16(2):307-16. PubMed ID: 25756513
[TBL] [Abstract][Full Text] [Related]
37. Inflammation and Wasting of Skeletal Muscles in Kras-p53-Mutant Mice with Intraepithelial Neoplasia and Pancreatic Cancer-When Does Cachexia Start?
Hildebrandt W; Keck J; Schmich S; Bonaterra GA; Wilhelm B; Schwarzbach H; Eva A; Bertoune M; Slater EP; Fendrich V; Kinscherf R
Cells; 2022 May; 11(10):. PubMed ID: 35626644
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneity of weight loss and transcriptomic signatures in pancreatic ductal adenocarcinoma.
Riner AN; Herremans KM; Vudatha V; Han S; Qu X; Liu J; Mukhopadhyay N; Freudenberger DC; George TJ; Judge SM; Judge AR; Hughes SJ; Trevino JG
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):149-158. PubMed ID: 38123146
[TBL] [Abstract][Full Text] [Related]
39. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.
Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I
J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419
[TBL] [Abstract][Full Text] [Related]
40. Glucose metabolism during tumorigenesis in the genetic mouse model of pancreatic cancer.
Pasquale V; Dugnani E; Liberati D; Marra P; Citro A; Canu T; Policardi M; Valla L; Esposito A; Piemonti L
Acta Diabetol; 2019 Sep; 56(9):1013-1022. PubMed ID: 30989379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
